This article is a review of the main concepts about In silico modeling of diseases. Examples and applications of In silico modeling for some important categories of diseases (such as for cancers, infectious diseases, and neuronal diseases) are also given.
View this resource Bookmark this resourceDisease Model
In this section you will have the opportunity to explore cellular models:
patient-derived immortalized cell lines, and animal models
Patient-derived induced pluripotent stem cell (iPSCs)
Organoid
You can also find information regarding animal models:
Zebra Fish
Fruit fly
Mouse
Rat
Non-human primates
This website provides In silico modeling tools to measure key aspects affecting the performance of nanomedicines release. It offers physiologically-based biopharmaceutics (PBB) modeling with the aims to support the development of the novel in vitro methods.
View this resource Bookmark this resource
In Silico Model in Toxicology and Risk Assessment
Published by Frontiers Media
In silicophysiologically-based kinetic and dynamic modelQSAR modelThis article aims to address the latest developments in the area of In silico modelling and New approach methodologies (NAMs) including physiologically-based kinetic and dynamic (PBK-D) model, In silico model for the prediction of toxicological such as QSAR model and machine learning algorithms, the use of quantitative adverse outcome pathways for hazard characterisation of chemicals to cite but a few
View this resource Bookmark this resource
In silico Methods for Drug Design and Discovery
Published by Computers in Biology and Medicine
In sillicomethodstoolsIn this review,is briefly introduced computational drug discovery strategies and outline up-to-date tools to perform the strategies as well as available knowledge bases for those who develop their own computational model.
View this resource Bookmark this resource
Animal models for metabolic, neuromuscular and ophthalmological rare diseases
Published by Macmillan Publishers Limited
Animal ModelFeline ModelInfrafrontierMouse ModelNeuromuscular DiseaseOphtalmological Diseasethe article provides a compilation of mammalian animal
models for metabolic, neuromuscular and ophthalmological orphan-designated conditions
based on information gathered by the EMA’s Committee for Orphan Medicinal Products (COMP). It is discussed the predictive value of the models and their advantages and limitations with the aim of highlighting those that are appropriate for the preclinical evaluation of novel
therapies, thereby facilitating further drug development for rare diseases.
KNOCKOUTS MODEL THE 100
BEST-SELLING DRUGS — WILL THEY
MODEL THE NEXT 100?
Published by Nature
Knock-Out Mouse Modelthis article is a retrospective evaluation of the knockout phenotypes for the targets of the 100 best-selling drugs indicates that these phenotypes correlate well with known drug efficacy, illuminating a productive path forward for discovering future drug targets
View this resource Bookmark this resourcelist ofresearch publications of the Infrafrontier Research infrastructures
View this resource Bookmark this resourceA Contract Research Organization that uses zebrafish to carry out a number of experimental services focused on analyzing the Safety, efficacy and biomedical relevance of new compounds. In the website it can be found resources, data bases and research publications.
View this resource Bookmark this resource
Nonhuman Primate Models in the Genomic Era: A Paradigm Shift
Published by ILAR J.
Non-Human Primate ModelThis article describes the genetic and genomic revolution thath is changing the paradigm of the nonhuman primates as a disease model and the new mandates on how nonhuman primates are used in biomedical research.
View this resource Bookmark this resource
Mammalian animal models for Duchenne muscular dystrophy
Published by Elsevier B.V
Duchenne Muscular DystrophyMammalian Animal ModelThis review compares the currently used mammalian animal models for DMD with the aim of selecting and recommending the most appropriate ones for preclinical efficacy testing of new therapeutic strategies.
View this resource Bookmark this resource
